We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Panel Calls NIH Out Again on Safety of Patients Affected by PDS Shutdown
House Panel Calls NIH Out Again on Safety of Patients Affected by PDS Shutdown
The House Energy & Commerce Committee is once again demanding information on the status of all patients in NIH clinical trials affected by the shutdown of the agency’s drug compounding facility, despite receiving a letter from NIH saying there were no negative impacts on affected patients.